
Game-changing obesity drugs go mainstream: what scientists are learning
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
NEWS 23 May 2023 Game-changing obesity drugs go mainstream: what scientists are learning Studies tackle who’s most likely to lose weight on the new generation of anti-obesity medications. By
Mariana Lenharo Mariana Lenharo View author publications You can also search for this author in PubMed Google Scholar
Twitter Facebook Email Access through your institution Buy or subscribe A new generation of drugs is revolutionizing the treatment of obesity and astonishing researchers with their potency.
The drug semaglutide, for example, enabled one-third of clinical-trial participants to shed at least 20% of their body weight1. Tirzepatide, a competing therapy, achieved similar results in
more than half of study participants2.
Access options Access through your institution Additional access options: Log in Learn about institutional subscriptions Read our FAQs Contactcustomer support
Nature 618, 17-18 (2023)
doi: https://doi.org/10.1038/d41586-023-01712-8
References Wilding, J. P. H. et al. N. Engl. J. Med. 384, 989–1002 (2021).
Article PubMed Google Scholar
Jastreboff, A. M. et al. N. Engl. J. Med. 387, 205–216 (2022).
Article PubMed Google Scholar
Acosta, A. et al. Obesity 29, 662–671 (2021).
Article PubMed Google Scholar
Jensterle, M. et al. Endocr. Abstr. 81, OC5.2 (2022).
Article Google Scholar
Rubino, D. et al. JAMA 325, 1414–1425 (2021).
Article PubMed Google Scholar
Download references
Reprints and permissions
Related Articles The ‘breakthrough’ obesity drugs that have stunned researchers
The vicious cycle of depression and obesity
The sting of sizeism in the scientific workplace
Common sweetener suppresses mouse immune system — in high doses
Subjects Obesity Medical research Metabolism Latest on: Obesity Mice lacking this amino acid lost 30% of their body weight
News 21 MAY 25
How much ultra-processed food do you eat? Blood and urine record it
News 20 MAY 25
Losing weight through better sleep
Outlook 09 APR 25
Medical research Medicine’s rapid adoption of AI has researchers concerned
News 09 JUN 25
Sticky membranes of dead red blood cells obstruct small vessels
News & Views 04 JUN 25
Y-chromosome loss in cancer and immune cells might worsen treatment outcomes
News & Views 04 JUN 25
Metabolism Unravelling cysteine-deficiency-associated rapid weight loss
Article 21 MAY 25
Mice lacking this amino acid lost 30% of their body weight
News 21 MAY 25
How much ultra-processed food do you eat? Blood and urine record it
News 20 MAY 25
Jobs Post-Doctoral Fellowship in Regenerative Biology and Medicine (Lab of. Dr. Yuval Rinkevich) Discovery of cellular and molecular mechanisms of tissue repair and regeneration.
Beijing, China
The Chinese Institutes for Medical Research (CIMR), Beijing
Tenure-track Assistant Professor towards Associate Professor in the field of metabolic diseases UNIL is a leading international teaching and research institution, with over 5,000 employees
and 15,500 students split between its Dorigny campus, ...
Lausanne, Canton of Vaud (CH)
University of Lausanne (UNIL)
Associate or Senior Editor (Nature Structural & Molecular Biology and Nature Communications) Job Title: Associate or Senior Editor (Nature Structural & Molecular Biology and Nature
Communications) Location: New York, Shanghai, Beijing, Mad...
New York City, New York (US)
Springer Nature Ltd
Postdoctoral Associate – Nima Sharifi Laboratory The Nima Sharifi Laboratory is seeking to recruit outstanding postdoctoral associates with a primary interest in the fundamental mechanisms
of huma...
Miami, Florida (US)
University of Miami Desai Sethi Urology Institute
Associate or Senior Editor, BMC Medicine Job Title: Associate or Senior Editor, BMC Medicine Location(s): Shanghai – Hybrid working model Application Deadline: June 25th, 2025 About
Spri...
Shanghai – Hybrid working model
Springer Nature Ltd